BREAKING
Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 49 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 49 minutes ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 3 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 5 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 7 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 8 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 8 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 9 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 11 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 11 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 12 hours ago
ADVERTISEMENT
Market News

What to expect when Altria (MO) reports first quarter 2024 earnings results

Shares of Altria Group, Inc. (NYSE: MO) stayed green on Wednesday. The stock has dropped 8% over the past one month. The tobacco giant is scheduled to report its first quarter 2024 earnings results on Thursday, April 25, before markets open. Here’s what to expect from the earnings report: Revenue Analysts are projecting revenue of […]

$MO April 17, 2024 2 min read

Shares of Altria Group, Inc. (NYSE: MO) stayed green on Wednesday. The stock has dropped 8% over the past one month. The tobacco giant is scheduled to report its first quarter 2024 earnings results on Thursday, April 25, before markets open. Here’s what to expect from the earnings report:

Revenue

Analysts are projecting revenue of $4.7 billion for Altria in the first quarter of 2024. This compares to revenue of $5.7 billion reported in the same period a year ago. In the fourth quarter of 2023, net revenues decreased 2% year-over-year to $5.9 billion.

Earnings

The consensus estimate for EPS in Q1 2024 is $1.15, which compares to adjusted EPS of $1.18 reported in Q1 2023. In Q4 2023, adjusted EPS remained flat YoY at $1.18.

Points to note

Altria’s top line has been on a downward trend for the past couple of quarters pressured by declines in its smokeable products segment. Last quarter, smokeable products revenue fell 3% due to lower shipment volume and higher promotional investments.

The cigarette industry has been facing challenges with inflationary pressures weighing on tobacco consumers’ discretionary income. This, along with the growth of illicit e-vapor products, led to an estimated 8% decline in industry cigarette volumes last year. Altria’s domestic cigarette shipment volume decreased 7.6% in Q4.

ADVERTISEMENT

The company has been able to offset the headwinds in its smokeable products division through price increases to some extent but there are concerns that this strategy may not hold up over the long term.

Meanwhile, Altria’s efforts in expanding its smoke-free products portfolio is expected to prove beneficial. On its last quarterly call, the company said smoke-free alternatives comprise around 40% of the total nicotine space. E-vapor is the largest smoke-free category and Altria has the opportunity to expand further in this space through its acquisition of NJOY.

Altria is also expected to benefit from growth in its oral tobacco products segment which saw revenues rise over nearly 7% in Q4. The company saw shipment volumes for on! nicotine pouches grow around 33% in Q4.

ADVERTISEMENT